Skip to main content

Table 1 Number of episodes by age category

From: Efficacy and safety of i.v. sodium benzoate in urea cycle disorders: a multicentre retrospective study

Age category

Patients

N = 61 (%)

0–27 days

25 (26.3 %)

1-23 months

14 (14.7 %)

2–11 years

40 (42.1 %)

12–17 years

10 (10.5 %)

≥18 years

6 (6.3 %)

Back to article page

Orphanet Journal of Rare Diseases

ISSN: 1750-1172